Stay updated on Oral Voxelotor in Sickle Cell Disease Clinical Trial
Sign up to get notified when there's something new on the Oral Voxelotor in Sickle Cell Disease Clinical Trial page.

Latest updates to the Oral Voxelotor in Sickle Cell Disease Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoChange DetectedRevision: v3.5.2 is now displayed on the page. The previous Revision: v3.5.0 has been removed.SummaryDifference0.0%

- Check14 days agoChange DetectedPadua, Italy, 35128 was replaced by Padova, Italy, 35128 in the Locations list (same postal code). This standardizes the site name to the local designation and improves accuracy in site identification for potential participants and staff.SummaryDifference0.0%

- Check22 days agoChange DetectedHb SS disease is listed as a related term; Genetic and Rare Diseases Information Center is added as a resource.SummaryDifference0.1%

- Check36 days agoChange DetectedThe page displays Revision: v3.5.0, replacing Revision: v3.4.3.SummaryDifference0.0%

- Check43 days agoChange DetectedRevision: v3.4.3 was added and Revision: v3.4.2 was removed from the page.SummaryDifference0.0%

- Check71 days agoChange DetectedAdded Revision: v3.4.2. Removed the earlier notices about government funding interruptions and operating status (Revision: v3.4.1).SummaryDifference0.3%

Stay in the know with updates to Oral Voxelotor in Sickle Cell Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Oral Voxelotor in Sickle Cell Disease Clinical Trial page.